Financials

  • Market Capitalization 3.82 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1533
DNLI
Denali Therapeutics Inc. - Common Stock
24.03 USD-2.59%-3.49%+0.63%+48.61%3.84 B USD
1537
VKTX
Viking Therapeutics, Inc. - Common Stock
32.57 USD-3.81%-5.26%-3.78%+17.75%3.80 B USD
1555
RCUS
Arcus Biosciences, Inc. Common Stock
29.44 USD-3.79%-3.03%+7.09%+175.91%3.75 B USD
1568
LEGN
Legend Biotech Corporation - American Depositary Shares
19.96 USD-2.63%-10.49%+3.96%-37.59%3.69 B USD